A Neurotrophic & Nootropic Formulation with BDNF and NGF mRNA Expression Enhancement Features for the Treatment of Neurological Damage & Development Disorders (BDNF NGF Neurotrophin)
A Neurotrophic and Nootropic Formulation consisting of a Pro-Somathropic Dioscin Analouge with increased systemic duration due to prolonged half-life, a Gymnemic Acid Analouge with BDNF NGF and Neurotrophin B3 mRNA Expression Enhancing Properties. Formulation may serve as an adjuvant curative…
